Inhibikase Therapeutics
Inhibikase Therapeutics is a clinical stage pharmaceutical company developing small-molecule kinase inhibitors for neurodegenerative diseases and pulmonary arterial hypertension.
Equisolve Logo
About Equisolve
Inhibikase Therapeutics Inc is a clinical stage pharmaceutical company focused on developing and commercializing small-molecule kinase inhibitor therapeutics. Its research targets the safe and effective treatment of neurodegenerative diseases inside and outside the brain, as well as conditions such as pulmonary arterial hypertension.
Year founded
2010
Number of employees
0-100
Sector
Health Care
Industry Group
Pharmaceuticals, Biotechnology & Life Sciences
Industry
Biotechnology
Report inaccurate data
Request an update to help us keep the brand up-to-date.
